Azora Therapeutics, Inc. (DE)

SEC 4 · Filed

0001104659-26-079686Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 29, 2026

Purchase by Coastlands Capital LP

Security
Common Stock
Code
P
Shares
25,000
Price per share
2.60
Structured facts
{
  "code": "P",
  "date": "2026-06-29",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person\u0027s pecuniary interest therein."
  },
  "owners": [
    {
      "cik": "0002068530",
      "name": "Coastlands Capital LP",
      "roles": [
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "373322",
  "price": "2.60",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "25000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}